[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,433,345
  • Shares Outstanding, K 219,616
  • Annual Sales, $ 51,950 K
  • Annual Income, $ -265,940 K
  • EBIT $ -314 M
  • EBITDA $ -310 M
  • 60-Month Beta 0.93
  • Price/Sales 46.88
  • Price/Cash Flow N/A
  • Price/Book 4.67

Options Overview Details

View History
  • Implied Volatility 63.48% (+4.97%)
  • Historical Volatility 55.57%
  • IV Percentile 3%
  • IV Rank 2.70%
  • IV High 363.10% on 02/13/26
  • IV Low 55.16% on 08/26/25
  • Expected Move (DTE 25) 1.21 (11.17%)
  • Put/Call Vol Ratio 0.10
  • Today's Volume 754
  • Volume Avg (30-Day) 3,211
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 65,326
  • Open Int (30-Day) 51,492
  • Expected Range 9.60 to 12.02

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.36
  • Number of Estimates 6
  • High Estimate $-0.34
  • Low Estimate $-0.37
  • Prior Year $-0.37
  • Growth Rate Est. (year over year) +2.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.15 +31.41%
on 07/31/26
11.74 -8.77%
on 08/19/26
+2.20 (+25.93%)
since 07/24/26
3-Month
8.07 +32.70%
on 06/09/26
11.74 -8.77%
on 08/19/26
+2.48 (+30.13%)
since 05/22/26
52-Week
6.23 +71.91%
on 02/17/26
16.44 -34.85%
on 12/08/25
-1.59 (-12.93%)
since 08/22/25

Most Recent Stories

More News
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 10.67 (-3.70%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 10.67 (-3.70%)
Ocular Therapeutix (NASDAQ:OCUL) Beats Expectations in Strong Q2 CY2026

Ocular Therapeutix (NASDAQ:OCUL) Beats Expectations in Strong Q2 CY2026

OCUL : 10.67 (-3.70%)
Ocular Therapeutix: Q2 Earnings Snapshot

Ocular Therapeutix: Q2 Earnings Snapshot

OCUL : 10.67 (-3.70%)
Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights

Ocular’s AXPAXLI TM wet AMD NDA submission on track for Q4 2026 following positive Type C Meeting with the U.S. FDA in May 2026 FDA Type C Meeting Minutes Formalize SOL-1 Trial with Confirmatory...

OCUL : 10.67 (-3.70%)
3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals

NEO : 16.67 (-1.83%)
AORT : 27.71 (-1.32%)
OCUL : 10.67 (-3.70%)
3 Russell 2000 Stocks That Concern Us

3 Russell 2000 Stocks That Concern Us

TFIN : 74.13 (-1.09%)
BKU : 46.33 (+0.09%)
OCUL : 10.67 (-3.70%)
Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers

Pharmaceuticals Stocks Q1 In Review: Ocular Therapeutix (NASDAQ:OCUL) Vs Peers

OCUL : 10.67 (-3.70%)
3 Cash-Burning Stocks with Open Questions

3 Cash-Burning Stocks with Open Questions

MSTR : 124.66 (+4.54%)
RDNT : 75.66 (-1.51%)
OCUL : 10.67 (-3.70%)
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., July 09, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina...

OCUL : 10.67 (-3.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular...

See More

Key Turning Points

3rd Resistance Point 11.96
2nd Resistance Point 11.72
1st Resistance Point 11.40
Last Price 10.67
1st Support Level 10.85
2nd Support Level 10.61
3rd Support Level 10.29

See More

52-Week High 16.44
Fibonacci 61.8% 12.54
Fibonacci 50% 11.34
Last Price 10.67
Fibonacci 38.2% 10.13
52-Week Low 6.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.